DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) had its target price hoisted by stock analysts at Stifel Nicolaus from C$25.00 to C$26.00 in a note issued to investors on Tuesday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 36.13% from the stock’s previous close.
Several other research analysts have also commented on DHT.UN. Canaccord Genuity Group increased their price target on shares of DRI Healthcare Trust from C$22.25 to C$23.00 and gave the stock a “buy” rating in a research note on Tuesday, June 30th. Raymond James Financial lifted their price objective on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company a “strong-buy” rating in a research note on Monday, June 29th. Scotiabank upped their price objective on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the stock a “sector outperform” rating in a report on Tuesday, May 19th. Finally, National Bank Financial increased their target price on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the stock an “outperform” rating in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of C$25.20.
Check Out Our Latest Stock Report on DHT.UN
DRI Healthcare Trust Price Performance
DRI Healthcare Trust Company Profile
DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.
Featured Stories
- Five stocks we like better than DRI Healthcare Trust
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
